- Covid Rapid Antigen Test *NEW* Price - $50.00
- No Appointments required - Call 716-799-8700
Get Healthy!
Results for search "Drugs: Misc.".
06 Jun
Prolonged Use of GLP-1 Receptor Agonists May Increase the Risk for a Serious Eye Condition
People with diabetes who use GLP-1 receptor agonists like semaglutide are more likely to develop neovascular age-related macular degeneration, a new study finds.
Health News Results - 87
Eli Lilly reached a major milestone Friday, becoming the first healthcare company in the world to hit a $1 trillion market value.
The drug company briefly crossed the trillion-dollar mark during morning trading before its stock pulled back slightly. Shares were last trading at around $1,048 each.
Eli Lilly is now just the second non-technology co...
- I. Edwards HealthDay Reporter
- |
- November 24, 2025
- |
- Full Page
New guidelines recommend doctors tackle Crohn’s disease head-on, calling for the use of cutting-edge drugs as early as possible to quell the autoimmune GI disorder as quickly as possible.
The updated American Gastroenterological Association guidelines reject a &...
- Dennis Thompson HealthDay Reporter
- |
- November 20, 2025
- |
- Full Page
The U.S. Food and Drug Administration (FDA) is tightening restrictions on a gene therapy used to treat Duchenne muscular dystrophy after two teenagers died from liver failure linked to the medication.
The FDA decision limits the use of Elevidys, made by Sarepta Therapeutics, to boys who are 4 years an...
- I. Edwards HealthDay Reporter
- |
- November 17, 2025
- |
- Full Page
The U.S. Food and Drug Administration (FDA) has appointed one of its most respected cancer drug regulators to lead the agency’s main division for approving new drugs.
The appointment of Dr. Richard Pazdur comes after a turbulent year with hundreds of staff departures within the agency.
Pazdur, who has ...
- I. Edwards HealthDay Reporter
- |
- November 13, 2025
- |
- Full Page
Texas Attorney General Ken Paxton has filed a lawsuit accusing Kenvue, the maker of Tylenol, and its former parent company, Johnson & Johnson, of misleading consumers about the safety of the popular pain reliever during pregnancy.
Filed Tuesday in Texas state court, the lawsuit claims...
- I. Edwards HealthDay Reporter
- |
- October 29, 2025
- |
- Full Page
The maker of Tylenol is urging U.S. health regulators not to add an autism warning label to it and other pain-relievers containing acetaminophen, calling the request “unsupported by the scientific evidence and legally and procedurally improper."
Kenvue’s response, dated Oct. 17, came after a citizen petition sought new pregnancy warnings f...
- I. Edwards HealthDay Reporter
- |
- October 22, 2025
- |
- Full Page
A new analysis reveals how deeply the U.S. drug supply chain depends on China, and experts warn that a trade war could leave American patients at risk.
Nearly 700 medicines used in the U.S. contain at least one chemical sourced only in China, according to U.S. Pharmacopeia, a nonprofit that monitors the drug supply.
Those chemicals are crucia...
- I. Edwards HealthDay Reporter
- |
- October 17, 2025
- |
- Full Page
Dangerous infections that no longer respond to antibiotics are spreading quickly around the world, increasing by as much as 15% a year, according to a new report from the World Health Organization (WHO).
The report found that 1 in 6 infections worldwide in 2023 was resistant to common antibiotics, including drugs used to treat
A recently approved injectable drug can significantly stall deteriorating health among people newly diagnosed with the most severe form of high blood pressure, a new study says.
Sotatercept reduced patient’s risk of ...
- Dennis Thompson HealthDay Reporter
- |
- October 6, 2025
- |
- Full Page
An approved pill for Alzheimer’s disease might help boost social functioning in some children and teens with autism spectrum disorder, a new small-scale clinical trial has found.
Memantine improved these kids’ social behaviors 56%, com...
- Dennis Thompson HealthDay Reporter
- |
- October 6, 2025
- |
- Full Page
The maker of Tylenol is pushing back against resurfaced claims that its popular pain reliever is unsafe for pregnant women.
Kenvue, the parent company of Tylenol, issued a statement Thursday after an old and now-deleted 2017 social media post resurfaced suggesting it did not recommend &ldqu...
- I. Edwards HealthDay Reporter
- |
- September 26, 2025
- |
- Full Page
A single dose of LSD eased anxiety symptoms for many folks and the benefits lasted up to three months, a new study reports.
The findings were published Sept. 4 in the Journal of the American Medical Association.
Researchers tested several doses of LSD in nearly 200 patients with moder...
- I. Edwards HealthDay Reporter
- |
- September 5, 2025
- |
- Full Page
Veterans who receive traumatic brain injuries in combat often experience crippling post-traumatic stress disorder, anxiety and depression, leaving them hopeless and potentially suicidal.
But help might be on the way from an unlikely source – a psychedelic drug called ibogaine.
The drug, derived from the roots of an African shr...
- HealthDay Reporter
- Dennis Thompson
- |
- July 25, 2025
- |
- Full Page
More pregnant women are turning to newer and potentially safer antiseizure medications, a new study says.
Older antiseizure drugs like valproate and phenobarbital are known to increase risk of birth defects.
But there’s been a 30% increase in the use of the safest antiseizure drugs during pregnancy, researchers report in the July 23 issue of
Hives can drive a person crazy, covering parts of the body with maddeningly itchy welts.
Now, a new evidence review has identified the most effective treatments for people who suffer from chronic hives.
The small, colorful bottles hawked at convenience stores, smoke shops and filling stations as cognitive supplements or energy are often called "gas station heroin."
And, the U.S. Food and Drug Administration (FDA) warns that they pose similar risks of addiction and life-threatening side effects.
Amid a rise in calls to U.S. poison control centers, it recently reminded health p...
- HealthDay Reporter
- Carole Tanzer Miller
- |
- June 17, 2025
- |
- Full Page
Texas has moved to fund research into ibogaine, a psychedelic drug that may help treat addiction, depression and brain injuries.
Gov. Greg Abbott signed a bill last week approving $50 million in state funds for ibogaine research, The New York Times reported.
The goal is to support clinic...
- HealthDay Reporter
- I. Edwards
- |
- June 16, 2025
- |
- Full Page
A new breakthrough can help people with schizophrenia keep up with their psychiatric meds, researchers said.
A pill taken just once a week, gradually releasing medicine from within the stomach, can greatly simplify the drug schedule faced by schizophrenia patients, researchers reported June 10 in the journal
Attorneys general from four states are asking the U.S. Food and Drug Administration (FDA) to lift restrictions on mifepristone, a pill used in medication abortions.
The request came Thursday from top officials in California, Massachusetts, New Jersey and New York.
They said in a petition that the current rules make it too hard fo...
- HealthDay Reporter
- I. Edwards
- |
- June 6, 2025
- |
- Full Page
U.S. Health and Human Services Secretary Robert F. Kennedy Jr. has ordered a fresh safety review of mifepristone, a drug commonly used in medication abortions.
He asked Dr. Marty Makary, commissioner of the U.S. Food and Drug Administration (FDA...
- HealthDay Reporter
- I. Edwards
- |
- June 5, 2025
- |
- Full Page
Pepto Bismol is a go-to stomach remedy, but a new study suggests it might not help prevent diarrhea during international travel.
The study, led by the U.S. Centers for Disease Control and Prevention (CDC), found that people who took bismuth subsalicylate — the active ingredient in
President Donald Trump's choice for U.S. surgeon general has raised eyebrows for promoting the use of psychedelic drugs, such as psilocybin, in a 2024 book and her personal newsletter.
His choice for the post is wellness influencer Dr. Casey Means, who was...
- HealthDay Reporter
- I. Edwards
- |
- May 15, 2025
- |
- Full Page
The 2023 approval of the first drug shown to slow the progression of Alzheimer’s disease came with no small amount of concern from skeptics.
Lecanemab (Leqembi) modestly slows Alzheimer’s b...
- HealthDay Reporter
- Dennis Thompson
- |
- May 15, 2025
- |
- Full Page
Drugs that battle HIV and hepatitis B might be able to help people avoid Alzheimer’s disease, a new study says.
Nucleoside reverse transcriptase inhibitors (NRTIs) are used to prevent HIV and hepatitis B from replicating and spreading...
- HealthDay Reporter
- Dennis Thompson
- |
- May 13, 2025
- |
- Full Page
More talk and fewer pills are being employed to help Americans maintain their mental health, a new study says.
Psychotherapy is assuming a larger role in mental health care, while medications prescribed without accompanying therapy are becoming less common, according to results published in early...
- HealthDay Reporter
- Dennis Thompson
- |
- May 9, 2025
- |
- Full Page
A new drug combo lowers "bad" LDL cholesterol for people whose levels remain high even after taking statins.
The new pill pairs a new drug called obicetrapib with an existing one, ezetimibe. In a Phase 3 clinical trial, this combo reduced LDL levels by nearly 49% over about three months, according to Cleveland Clinic researchers.
- HealthDay Reporter
- I. Edwards
- |
- May 8, 2025
- |
- Full Page
The cutting-edge weight-loss drug Ozempic/Wegovy can stop and even reverse fatty liver disease, a new clinical trial has found.
Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the orga...
- HealthDay Reporter
- Dennis Thompson
- |
- May 1, 2025
- |
- Full Page
Teen cannabis use rose significantly in parts of Canada after edibles were legalized, a new study shows.
The study found a 26% increase in teen cannabis use in provinces that began selling cannabis edibles and extracts in October 2019. Use of edibles alone jumped 43%, researchers reported April 18 in JAMA N...
Recreational use of “magic mushroom” psilocybin skyrocketed in the U.S. during the early 2020s, as states began toying with legalization of the psychedelic drug, a new study says.
The number of adults 30 and older who had used psilocybin in the past year increased by 188% between 2019 and 2023, researchers reported April 21 in the
A new pill designed to help with weight loss and blood sugar control is showing promise in early studies.
Eli Lilly said its experimental drug, orforglipron, helped people with type 2 diabetes lower their blood sugar and ...
- HealthDay Reporter
- I. Edwards
- |
- April 18, 2025
- |
- Full Page
An experimental drug can help patients with advanced multiple sclerosis (MS) delay the progressive disability that comes with their disorder, a new clinical trial suggests.
The drug, tolebrutinib, delayed disability progression by 31% in people with a type of MS called non-relapsing secondary progressive multiple sclerosis (SPM...
- HealthDay Reporter
- Dennis Thompson
- |
- April 9, 2025
- |
- Full Page
Florida’s insurance regulator is demanding detailed prescription data on millions of patients, raising alarms over patient privacy.
In January, the Florida Office of Insurance Regulation asked pharmacy benefit managers -- companies that manage prescription drug plans -- to hand over highly personal data about prescriptions filled in the state last year.
The data request includ...
- HealthDay Reporter
- I. Edwards
- |
- March 6, 2025
- |
- Full Page
A legal loophole is allowing marijuana ads to slip past regulations and land right in front of kids on social media, a new report shows.
Although the federal Controlled Substances Act prohibits advertising the sale or use of marijuana through federal airwaves or across state lines, these rules haven’t stopped social media ads on...
- HealthDay Reporter
- India Edwards
- |
- February 13, 2025
- |
- Full Page
Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's disease have taken an hit.
A new study found that a drug in the same class called exenatide, marketed as Byetta, had no effect on slowing the disease or easing its symt...
- HealthDay Reporter
- India Edwards
- |
- February 5, 2025
- |
- Full Page
Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions such as substance abuse, psychosis, infections and even dementia.
But these drugs also come with risks that shouldn't be overlooked, researchers warn ...
- HealthDay Reporter
- India Edwards
- |
- January 21, 2025
- |
- Full Page
When supplies of certain generic, platinum-based cancer chemotherapies dwindled in 2023, oncologists feared it might lead to under-treatment and many more cancer deaths.
Fortunately, that did not turn out to be the case, a new study published recently in the Journal of the National Cancer...
The U.S. Department of Justice (DOJ) has filed a civil complaint against CVS Pharmacy Inc., accusing the nation’s largest pharmacy chain of unlawfully filling prescriptions for highly addictive opioids and violating federal health care laws.
According to a news release published Dec. 18, 2024, the complaint also accuses CVS of seeking reimbursement for these prescriptions from feder...
- HealthDay Reporter
- India Edwards
- |
- December 19, 2024
- |
- Full Page
Synthetic antibiotics that attack bacteria in two directions at once could be the solution for combatting antimicrobial-resistant bugs, a new study claims.
These dual-action antibiotics, called macrolones, disrupt bacterial cell function in two different ways.
It’s nearly impossibl...
- HealthDay Reporter
- Dennis Thompson
- |
- July 25, 2024
- |
- Full Page
“Magic†mushrooms achieve their psychedelic effects by temporarily scrambling a brain network involved in introspective thinking like daydreaming and remembering, a new study reports.
Brain scans of people who took psilocybin -- the psychedelic drug in ‘shrooms -- revealed that the substance causes profound and widespread temporary changes to the brain’s default m...
- HealthDay Reporter
- Dennis Thompson
- |
- July 18, 2024
- |
- Full Page
A study based on online Google searches suggests surging U.S. interest in microdosing psychedelics, such as psilocybin, as rules around the use of such drugs begin to relax.
But the safety of these drugs isn't entirely clear, said study lead author Dr. Kevin Yang.
"As public interest in using psychedelics and cannabis for health g...
- HealthDay Reporter
- Ernie Mundell
- |
- July 1, 2024
- |
- Full Page
People who eat more ultra-processed foods are more likely to suffer an early death, particularly from heart disease or diabetes, a new study warns.
Older adults who consume higher amounts of ultra-processed foods are about 10% more likely to die than those w...
- HealthDay Reporter
- Dennis Thompson
- |
- July 1, 2024
- |
- Full Page
AI could help doctors cut back on the bewildering variety of medications that seniors frequently are prescribed, a new study suggests.
More than 40% of seniors are prescribed five or more meds, and this increases a person's risk of adverse drug interactions, researchers s...
- HealthDay Reporter
- Dennis Thompson
- |
- April 18, 2024
- |
- Full Page
When settling into your senior years, you need to be especially careful when taking medicines, herbal remedies and supplements, the U.S. Food and Drug Administration says.
That's because older adults are likely to use more prescription and over-the-counter medications, which increases the risk of harmful side effects and drug interactions, the FDA said in a
Nurse practitioners are just as good as primary care doctors at avoiding potentially harmful prescriptions for older patients -- but both need to do better, a large, new study suggests.
Nurse practitioners (NPs) are registered nurses with advanced training in doing many of the same things doctors do, including diagnosing diseases and devising treatment plans. As the United States continue...
- HealthDay Reporter
- Amy Norton
- |
- October 24, 2023
- |
- Full Page
The drugstore chain Rite Aid has filed for Chapter 11 bankruptcy, due largely to competition and thousands of lawsuits for its role in allegedly filling unlawful opioid prescriptions.
The company filed a notice Thursday with the U.S. Securities and Exchange Commission saying it would not be able to file its latest quarterly financial report before filing for bankruptcy on Sunday, CNN<...
- HealthDay Reporter
- Cara Murez
- |
- October 16, 2023
- |
- Full Page
Critics of a law that decriminalized drug possession in Oregon have blamed the policy for rising overdose deaths in the state, but a new study finds no evidence of that.
Researchers discovered that while drug overdose deaths have risen recently in Oregon, it appears the trend has no relation to a law popularly known as Measure 110.
Passed by Oregon voters in 2020, the policy decrim...
- HealthDay Reporter
- Amy Norton
- |
- September 28, 2023
- |
- Full Page
Psilocybin, the active ingredient in "magic" mushrooms, is getting renewed interest as a potential treatment for various health conditions. Now, a new research review argues that migraines should be added to that list.
Psilocybin mushrooms have long been used recreationally as hallucinogens -- meaning they alter users' perceptions of their surroundings. That can lead to euphoria on one en...
- HealthDay Reporter
- Amy Norton
- |
- August 14, 2023
- |
- Full Page
Tornado damage to a Pfizer drug-making plant in North Carolina is unlikely to trigger drug shortages across the country, the U.S. Food and Drug Administration says.
"We do not expect there to be any immediate significant impacts on supply, given the products are currently at hospitals and in the distribution system," FDA Commissioner
Surviving a trip to the emergency room for an opioid overdose dramatically increases a patient's odds of dying in the year after, U.S. health officials reported Tuesday.
Of nearly 287,000 emergency room visits in 2016, more than 8,300 were for opioid overdoses. Of these, nearly 500 patients were dead from a drug overdose in the following year and 400 died from other causes, according to a...
- HealthDay Reporter
- Steven Reinberg
- |
- May 24, 2023
- |
- Full Page